Adaptive responses to cefotaxime treatment in ESBL-producingEscherichia coliand the possible use of significantly regulated pathways as novel secondary targets-Reference-Cited by-同舟云学术

Adaptive responses to cefotaxime treatment in ESBL-producingEscherichia coliand the possible use of significantly regulated pathways as novel secondary targets

Published:2016-06-05 Issue:9 Volume:71 Page:2449-2459
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:J. Antimicrob. Chemother.

Author:

Møller Thea S. B.,Rau Martin H.,Bonde Charlotte S.,Sommer Morten O. A.,Guardabassi Luca,Olsen John E.

Funder

University of Copenhagen

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/71/9/2449/17430376/dkw198.pdf

Reference62 articles.

1. Resistance to cephalosporins and carbapenems in Gram-negative bacterial pathogens

2. Î²-Lactam induction of ISEcp1B-mediated mobilization of the naturally occurringblaCTX-MÎ²-lactamase gene ofKluyvera ascorbata

3. Epidemiology and genetics of CTX-M extended-spectrum β-lactamases in Gram-negative bacteria;Zhao;Crit Rev Microbiol,2012

4. Beta-lactamase induction and cell wall metabolism in Gram-negative bacteria

5. Canton R , Gonzalez-Alba JM , Galan JC . CTX-M enzymes: origin and diffusion. Front Microbiol 2012; 3: 110.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genome-wide identification of fitness-genes in aminoglycoside-resistant Escherichia coli during antibiotic stress;Scientific Reports;2024-02-20

2. Uncovering the Important Genetic Factors for Growth during Cefotaxime-Gentamicin Combination Treatment in blaCTX-M-1 Encoding Escherichia coli;Antibiotics;2023-06-01

3. Innovative Strategies to Overcome Antimicrobial Resistance and Tolerance;Microorganisms;2022-12-21

4. A whole-genome assay identifies four principal gene functions that confer tolerance of meropenem stress upon Escherichia coli;Frontiers in Antibiotics;2022-09-16

5. Global responses to oxytetracycline treatment in tetracycline-resistant Escherichia coli;Scientific Reports;2020-05-21